Researchers still found 'excellent' survival rates for both primary, secondary disease
by ranchipur on Thu Jul 04, 2013 02:57 PM
my father started zytiga about a year ago. prior to that his psa was pushing 300 and had metastasis to the bones. especially the pelvis area.
fortunately, after radiation, and chemotherapy(taxotir), and a year of zytiga, his psa dropped to 0.5. a blessing.
now the question is whether he should stop using zytiga, for a possible future need or simply continue. these decisions are diifficult to make due to deffering medical opinions. does anyone have a similar situation that can help us make our decision?
by POOKIETRAIN on Sat Jul 13, 2013 12:16 AM
Did he have a bone and CT scan recently? What does the oncologist say? I would think that the results of the scans dictate. Probably stay on.
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
Do you use smart phone apps?
Take our short survey on hospital smart phone apps.
We care about your feedback. Let us know how we can improve your CancerCompass experience.